The PPARgamma-selective ligand rosiglitazone differentially regulates the fate of choice of dental pulp mesenchymal stem cells versus bone marrow mesenchymal stem cells
碩士 === 國立陽明大學 === 臨床牙醫學研究所 === 97 === Tissue engineering with stem cells will be the future trend of medical treatment, and the source of stem cells can be isolated from different tissue of human body. Now we present the mesenchymal stem cells (MSCs) from dental pulp which is a luxury source of stem...
Main Authors: | Hung-Chang Lai, 賴泓璋 |
---|---|
Other Authors: | Shou-Yen Kao |
Format: | Others |
Language: | en_US |
Published: |
2009
|
Online Access: | http://ndltd.ncl.edu.tw/handle/64936094093287562347 |
Similar Items
-
Cell Fate and Differentiation of Bone Marrow Mesenchymal Stem Cells
by: Shoichiro Kokabu, et al.
Published: (2016-01-01) -
Functional characteristics of dental pulp mesenchymal stem cells
by: Pang, Y. W. Y.
Published: (2015) -
The Life and Fate of Mesenchymal Stem Cells
by: Elke eEggenhofer, et al.
Published: (2014-05-01) -
Regenerative medicine in dental and oral tissues: Dental pulp mesenchymal stem cell
by: Janti Sudiono, et al.
Published: (2016-03-01) -
Dental Pulp-Derived Mesenchymal Stem Cells for Modeling Genetic Disorders
by: Keiji Masuda, et al.
Published: (2021-02-01)